KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.20 $17.80 Friday, 26th Apr 2024 ENTA stock ended at $12.37. This is 0.88% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.66% from a day low at $12.20 to a day high of $12.65.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Apr 12, 2016 $29.95 $30.99 $29.82 $30.94 241 511
Apr 11, 2016 $29.86 $30.50 $29.57 $30.10 263 611
Apr 08, 2016 $29.79 $29.81 $28.82 $29.68 249 239
Apr 07, 2016 $29.52 $29.95 $29.00 $29.33 273 317
Apr 06, 2016 $29.47 $29.97 $29.10 $29.85 356 831
Apr 05, 2016 $29.01 $29.86 $28.83 $29.40 375 972
Apr 04, 2016 $29.70 $30.00 $29.18 $29.41 295 765
Apr 01, 2016 $29.11 $30.07 $28.93 $29.68 197 663
Mar 31, 2016 $28.73 $29.81 $28.71 $29.37 333 858
Mar 30, 2016 $28.20 $29.77 $28.20 $28.85 274 356
Mar 29, 2016 $27.09 $28.18 $26.30 $27.91 269 000
Mar 28, 2016 $27.15 $27.40 $26.64 $27.06 175 400
Mar 24, 2016 $26.46 $27.74 $25.83 $27.03 177 000
Mar 23, 2016 $28.01 $28.34 $26.41 $26.52 226 900
Mar 22, 2016 $27.37 $28.22 $27.09 $28.00 637 500
Mar 21, 2016 $26.99 $27.77 $26.95 $27.45 529 800
Mar 18, 2016 $27.38 $28.04 $26.58 $27.10 633 200
Mar 17, 2016 $27.15 $27.64 $26.48 $27.20 266 500
Mar 16, 2016 $27.19 $27.70 $26.41 $27.17 222 100
Mar 15, 2016 $28.96 $29.11 $26.88 $27.15 213 000
Mar 14, 2016 $29.26 $30.04 $28.00 $29.31 219 500
Mar 11, 2016 $29.04 $29.83 $28.38 $29.50 237 300
Mar 10, 2016 $28.84 $30.24 $28.48 $28.84 286 500
Mar 09, 2016 $28.60 $28.74 $27.76 $28.56 144 200
Mar 08, 2016 $30.41 $30.70 $28.33 $28.50 271 400
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT